Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children’s Oncology Group

Eitemau Tebyg

• Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group
  gan: Ho, Phoenix A., et al.
  Cyhoeddwyd: (2009)
• Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group
  gan: Ho, Phoenix A., et al.
  Cyhoeddwyd: (2010)
• BIRC5 (Survivin) Splice Variant Expression Correlates With Refractory Disease and Poor Outcome in Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group
  gan: Moore, Andrew S., et al.
  Cyhoeddwyd: (2013)
• High EVI1 Expression Is Associated with MLL Rearrangements and Predicts Decreased Survival in Paediatric AML: A Report From the Children’s Oncology Group
  gan: Ho, Phoenix A., et al.
  Cyhoeddwyd: (2013)
• Acute Myeloid Leukaemia (AML) with t(6;9)(p23;q34) is Associated with Poor Outcome in Childhood AML Regardless of FLT3-ITD Status: A Report from the Children’s Oncology Group
  gan: Tarlock, Katherine, et al.
  Cyhoeddwyd: (2014)